Literature DB >> 11889147

Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

Guillermo E Umpierrez1, Scott D Isaacs, Niloofar Bazargan, Xiangdong You, Leonard M Thaler, Abbas E Kitabchi.   

Abstract

Admission hyperglycemia has been associated with increased hospital mortality in critically ill patients; however, it is not known whether hyperglycemia in patients admitted to general hospital wards is associated with poor outcome. The aim of this study was to determine the prevalence of in-hospital hyperglycemia and determine the survival and functional outcome of patients with hyperglycemia with and without a history of diabetes. We reviewed the medical records of 2030 consecutive adult patients admitted to Georgia Baptist Medical Center, a community teaching hospital in downtown Atlanta, GA, from July 1, 1998, to October 20, 1998. New hyperglycemia was defined as an admission or in-hospital fasting glucose level of 126 mg/dl (7 mmol/liter) or more or a random blood glucose level of 200 mg/dl (11.1 mmol/liter) or more on 2 or more determinations. Hyperglycemia was present in 38% of patients admitted to the hospital, of whom 26% had a known history of diabetes, and 12% had no history of diabetes before the admission. Newly discovered hyperglycemia was associated with higher in-hospital mortality rate (16%) compared with those patients with a prior history of diabetes (3%) and subjects with normoglycemia (1.7%; both P < 0.01). In addition, new hyperglycemic patients had a longer length of hospital stay, a higher admission rate to an intensive care unit, and were less likely to be discharged to home, frequently requiring transfer to a transitional care unit or nursing home facility. Our results indicate that in-hospital hyperglycemia is a common finding and represents an important marker of poor clinical outcome and mortality in patients with and without a history of diabetes. Patients with newly diagnosed hyperglycemia had a significantly higher mortality rate and a lower functional outcome than patients with a known history of diabetes or normoglycemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11889147     DOI: 10.1210/jcem.87.3.8341

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  476 in total

1.  Stochastic targeted (STAR) glycemic control: design, safety, and performance.

Authors:  Alicia Evans; Aaron Le Compte; Chia-Siong Tan; Logan Ward; James Steel; Christopher G Pretty; Sophie Penning; Fatanah Suhaimi; Geoffrey M Shaw; Thomas Desaive; J Geoffrey Chase
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

Review 2.  Bio-ecological control of perioperative and ITU morbidity.

Authors:  Stig Bengmark
Journal:  Langenbecks Arch Surg       Date:  2003-11-07       Impact factor: 3.445

Review 3.  Blood glucose management during critical illness.

Authors:  Barry A Mizock
Journal:  Rev Endocr Metab Disord       Date:  2003-05       Impact factor: 6.514

4.  Effect of intensive vs conventional insulin therapy on perioperative nutritional substrates metabolism in patients undergoing gastrectomy.

Authors:  Han-Cheng Liu; Yan-Bing Zhou; Dong Chen; Zhao-Jian Niu; Yang Yu
Journal:  World J Gastroenterol       Date:  2012-06-07       Impact factor: 5.742

Review 5.  Hyperglycaemia in the acute care setting.

Authors:  Anjali Balasanthiran; Ben Zalin; Emma H Baker; Kevin Shotliff
Journal:  Clin Med (Lond)       Date:  2012-06       Impact factor: 2.659

6.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

Review 7.  Remote Monitoring and Consultation of Inpatient Populations with Diabetes.

Authors:  Robert J Rushakoff; Joshua A Rushakoff; Zachary Kornberg; Heidemarie Windham MacMaster; Arti D Shah
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

8.  Inpatient Management of Diabetes Mellitus among Noncritically Ill Patients at University Hospital of Puerto Rico.

Authors:  Myriam Zaydee Allende-Vigo; Rafael A González-Rosario; Loida González; Viviana Sánchez; Mónica A Vega; Milliette Alvarado; Raul O Ramón
Journal:  Endocr Pract       Date:  2014-05       Impact factor: 3.443

Review 9.  The Effects of Postprandial Exercise on Glucose Control in Individuals with Type 2 Diabetes: A Systematic Review.

Authors:  Andrew Borror; Gabriel Zieff; Claudio Battaglini; Lee Stoner
Journal:  Sports Med       Date:  2018-06       Impact factor: 11.136

10.  Improving health engagement and lifestyle management for breast cancer survivors with diabetes.

Authors:  Rebecca A Shelby; Caroline S Dorfman; Sarah S Arthur; Hayden B Bosworth; Leonor Corsino; Linda Sutton; Lynda Owen; Alaattin Erkanli; Francis Keefe; Cheyenne Corbett; Gretchen Kimmick
Journal:  Contemp Clin Trials       Date:  2020-04-11       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.